The ROS initiator, PMA, is also known as a potent tumor promoter that activates the signal transduction enzyme protein kinase C (PKC) and differentiates cancerous lymphocytes, such as THP-1 cells [36,37]. Here, PRRT2 is linked to neoplasm.